CD8A and COVID-19: Liu et al. [8] reported that thymosin could reverse T cell exhaustion and restore immune reconstruction by promoting thymic output during the severe COVID-19 infection period, especially in COVID-19 patients with the circulating CD8 + T cells or CD4 + T cell count < 400/μL or 650/μL, who could obtain more benefits from thymosin treatment.